ACHV
Achieve Life Sciences (ACHV)
$01
About Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Details
Daily high
$5.04
Daily low
$4.85
Price at open
$4.99
52 Week High
$5.98
52 Week Low
$3.03
Market cap
171.9M
Dividend yield
0.00%
Volume
146,704
Avg. volume
118,138
P/E ratio
-4.55
Achieve Life Sciences News
Details
Daily high
$5.04
Daily low
$4.85
Price at open
$4.99
52 Week High
$5.98
52 Week Low
$3.03
Market cap
171.9M
Dividend yield
0.00%
Volume
146,704
Avg. volume
118,138
P/E ratio
-4.55